MANGALAM.NS

Mangalam Drugs & Organics Limited MANGALAM.NS

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode MANGALAM.NS VAISHALI.NS PAR.NS BALPHARMA.NS BALPHARMA.BO MERCURYLAB.BO KREBSBIO.BO KREBSBIO.NS RAMAVISION.BO JSTL.BO
6M -45.63 % -33.28 % -13.06 % -28.79 % -28.38 % -9.91 % -20.18 % -19.83 % 54.03 % 67.53 %
YTD 62.74 % -0.23 % -9.20 % -2.22 % -2.43 % -4.42 % -4.92 % -5.74 % 4.06 % 5.35 %
1Y -55.98 % -45.17 % -52.63 % -39.01 % -38.24 % -10.11 % -30.39 % -33.40 % -2.14 % 42.48 %
3Y -62.25 % -42.59 % -41.77 % -19.05 % -18.87 % 3.19 % -38.83 % -38.05 % 130.49 % 18.44 %
5Y -63.06 % 51.60 % 176.85 % 30.17 % 30.55 % 32.01 % -47.70 % -47.31 % 130.49 % 87.88 %
10Y -82.44 % 93.64 % 85.22 % -36.02 % -35.72 % 84.97 % -42.33 % -32.66 % 130.49 % 36.28 %
From the beginning 31.65 % 93.64 % 85.22 % 18.31 % 610.89 % 7 900.00 % -76.04 % -32.66 % 130.49 % 156.14 %

Dividend

Mangalam Drugs & Organics Limited

Par Drugs and Chemicals Limited

Bal Pharma Limited

Bal Pharma Limited

Mercury Laboratories Limited

Krebs Biochemicals & Industries Limited

Krebs Biochemicals & Industries Limited

Jeevan Scientific Technology Limited